Columbus Circle Investors’s Amgen AMGN Stock Holding History

Columbus Circle Investors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,000	Closed	-$5.12M	–	273
2016 Q4	$5.12M	Buy	+35,000	New	+$5.27M	0.07%	185

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Columbus Circle Investors's AMGN Position: Q2 2017 in Review

Columbus Circle Investors sold out of Amgen (AMGN) in Q2 2017, closing a stake of 7,294 shares — an estimated $1.2M sold.

Columbus Circle Investors first reported a position in AMGN in Q2 2013 and held it in 13 quarters. The position peaked at $37.5M in Q2 2014. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

Columbus Circle Investors reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
Columbus Circle Investors sold 7,294 Amgen shares in Q2 2017, an estimated $1.2M.
Columbus Circle Investors first reported a position in Amgen in Q2 2013 and held it in 13 quarters.
Columbus Circle Investors's Amgen position peaked at $37.5M in Q2 2014.
1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.